SCHEMBL3945053

SCHEMBL3945053

C=CCNC(C)(C)[C@H]1CCC[C@@H](C(=O)OC)C1

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.33
NPSR1 Q6W5P4 2/20 0.32
ADRB2 P07550 1/20 0.32
ADRB1 P08588 1/20 0.32
ADRB3 P13945 1/20 0.32
ALDH1A1 P00352 2/20 0.32
BTK Q06187 1/20 0.31
CHRNB2 P17787 1/20 0.30
CHRNB4 P30926 1/20 0.30
CHRNA3 P32297 1/20 0.30
CHRNA7 P36544 1/20 0.30
CHRNA4 P43681 1/20 0.30
HTR1A P08908 1/20 0.30
CHRM2 P08172 1/20 0.30
CHRM4 P08173 1/20 0.30
CHRM3 P20309 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4020718 0.76 CTSD (0.39) SMN1; SMN2ADRB2ADRB1ADRB3ALDH1A1
SCHEMBL20351887 0.76 CHRNB2 (0.43) SMN1; SMN2ALDH1A1BTKCHRNB2CHRNB4
SCHEMBL20043197 0.76 CHRNB2 (0.43) SMN1; SMN2ALDH1A1BTKCHRNB2CHRNB4
SCHEMBL20047644 0.76 CHRNB2 (0.43) SMN1; SMN2ALDH1A1BTKCHRNB2CHRNB4
SCHEMBL3942643 0.76 SMN1; SMN2 (0.39) SMN1; SMN2ALDH1A1BTKCHRNB2CHRNB4
SCHEMBL4030544 0.76 SMN1; SMN2 (0.39) SMN1; SMN2ALDH1A1BTKCHRNB2CHRNB4
SCHEMBL20047572 0.74 ALDH1A1 (0.38) SMN1; SMN2ADRB2ADRB1ADRB3ALDH1A1
SCHEMBL4026636 0.73
SCHEMBL15443019 0.71 SMN1; SMN2 (0.40) SMN1; SMN2ALDH1A1BTKCHRNB2CHRNB4
SCHEMBL62434 0.70 SMN1; SMN2 (0.50) KMT2ASMN1; SMN2ALDH1A1BTKCHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009013293-A1 SUBSTITUTED CYCLOHEXANECARBOXAMIDES USEFUL AS BACE INHIBITORS NOVARTIS AG (CH) 2009-01-29 WO disclosed